What is lobular carcinoma in situ?

lobular carcinoma in situ applies to a collection of abnormal cells in breast tissue, which may potentially change over five years. The condition is difficult to detect and is usually unnoticed if the breast tissue biopsy is not performed to check another problem. While lobular carcinoma in situ does not cause physical symptoms, most doctors encourage patients to take medication or undergo surgery to reduce the risk of cancer in the future. The woman's breast

contains several hundred lobles, glands that produce milk. Lobular carcinoma in situ occurs when the cells along the inner lobby cladding begin to grow unusually large and quickly replicate at speed. Doctors do not know what triggers the abnormal development of cells, but it is assumed that genetics plays an important role. The condition may be present only on one breast or affect the lobes on both breasts. Women aged 20 to 50 are most commonly affected and only about 25 percent of patients diagnosedH with lobular carcinoma in situ has sometimes developed malignant breast cancer.

women who have lobular carcinoma in situ will probably not have symptoms. Usually there are no noticeable changes in the appearance or breast feeling. As a result, most cases of lobular cancer in situ are never diagnosed, or they are only recognized after cells change cancer and begin to cause health problems. Some cases are detected randomly after tests to study suspicious lumps or cysts in the breast.

Once lobular carcinoma in situ is identified, the doctor can describe in detail the condition and explain different treatment options. It is usually impossible to predict whether abnormal cells sometimes become cancer, but steps to reduce risk can be taken. Many doctors and patients prefer to avoid the treatment of the initial condition and instead plan regular breast tests to see ifChanges will start.

If early treatment is required, it is a common possibility to use a synthetic hormonal supplement that inhibits estrogen activity in the breast. Drugs such as Tamoxifen and Raloxifen block estrogen signals that normally trigger cell replication, thereby slowing or stopping the growth of abnormal cells. Finally, surgery to remove part of the first or both breasts can be considered if the patient is considered an extremely high risk of breast cancer. Most cases of lobular cancer in situ are completely solved by hormonal and surgical therapy.